摘要:
The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics.
摘要:
The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics.
摘要翻译:本发明提供包含SEQ ID NO:1的序列或其同源物的分离的肽或肽模拟物的组合,以及包含SEQ ID NO:2的序列的分离的肽或肽模拟物。本发明还提供了一种方法, 治疗受试者中的BCR-ABL相关疾病或c-ABL相关疾病。 该方法基于使用上述一种或多种分离的肽或肽模拟物的组合。